Question

Protein engineering and drug designing require CAMM (computer-aided molecular modeling) because of:
A) study of three-dimensional structures of receptors and functional molecules.
B) requirement of DNA recombinant technology.
C) specificity of proteins.
D) All of the above

Answer 1

Hint: Drug designing is the process of finding a new drug that is based on the knowledge of a biological target. It includes designing molecules that are complementary in shape and charge with the molecular target to which they have to interact and bind.

Complete step-by-step anwer:
A drug can activate or inhibit the function of a protein. A drug is nothing but a small organic molecule and gives therapeutic benefits. Drug designing is done on software in a computer as it relies on computer modeling techniques. This modeling is called computer-aided drug design. Structure-based drug design is the drug design that relies on the knowledge of the 3-D structure of the biomolecular target.
The process of developing significant proteins is called protein engineering. It involves an understanding of protein folding and recognition of protein design principles. It is used to improve the function of many enzymes that are used for industrial catalysis.
Hence the correct answer is option A.

Note: The drug design process is classified into two cases, based on whether the three-dimensional structure of the receptor Is known. If the structure is known, the relevant researchers include finding new types of lead compounds according to the structures of the receptors, studying the interactions between receptors and known compounds as well as optimising the lead compounds.